Form 4: Astera Labs Executive Sanjay Gajendra Sells Shares Under 10b5-1 Plan

Sanjay Gajendra, President and COO of Astera Labs, sold shares of common stock on May 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 8, 2025, Sanjay Gajendra, the President and COO of Astera Labs, sold shares of the company's common stock.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 30, 2024.
• The transactions involved multiple sales at varying prices, with weighted average prices reported for each set of transactions.
• The shares were sold from both direct holdings and holdings within estate planning trusts (Trust 1, Trust 2, and Trust 3).
• Gajendra disclaims beneficial ownership of the shares held in the trusts, except to the extent of any pecuniary interest.
• A total of 2,353,655 shares of common stock are still held directly by Gajendra.
• The sales prices ranged from approximately $69.99 to $73.51 per share.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Future Outlook

The document does not contain any forward-looking statements regarding the company's future performance.

Industry Context

This Form 4 filing is a routine disclosure of insider stock sales. It's common for executives to use Rule 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The impact on Astera Labs' stock will depend on the overall market sentiment and the size of the transactions relative to the company's trading volume.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
• The use of Rule 10b5-1 trading plans is a common strategy among executives to diversify their holdings and avoid potential conflicts of interest.
• Comparable companies like Marvell, Broadcom, and Nvidia also have executives who utilize similar trading plans, and their Form 4 filings are publicly available for comparison.

Stakeholder Impact

• The stock sales could have a minor impact on shareholder sentiment, depending on the market's interpretation of the transactions.
• The sales do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, Astera Labs, ALAB, Sanjay Gajendra, Rule 10b5-1, insider trading, stock sale, estate planning trust